Cancer Diagnostics – News and Features

The burden of cancer isn’t distributed evenly across the population, with health inequalities causing unfair differences in cancer outcomes.

Researchers at Fred Hutch and MD Anderson discovered RNA Polymerase II on histone genes as a biomarker for cancer aggressiveness. Using CUTAC technology, they accurately predicted tumor severity and recurrence in meningioma and breast cancer.

Scientists at Oregon Health & Science University developed PAC-MANN, a blood test that detects pancreatic cancer with 98% accuracy. The test identifies protease activity linked to tumors, allowing earlier detection and tracking of treatment response.

By sharing the stories of EDI champions in science, we hope to shed light on both the importance of diversity and the practical steps being taken to improve representation and inclusion.

New results indicate that AI-supported breast screening can detect 29% more cancer cases than traditional screening.

A study from Moffitt Cancer Center and the University of Michigan shows that AI-assisted radiotherapy can help doctors make more consistent treatment decisions for lung and liver cancer. However, doctors' trust in AI recommendations varies.

A study finds that celecoxib improves disease-free survival in stage 3 colon cancer patients with positive ctDNA after surgery. The analysis highlights ctDNA’s predictive role in identifying patients who may benefit from anti-inflammatory drugs.

In this article, Momin Shah discusses how to ensure that NGS protocols are optimized from the outset to save time and costs on new research projects.

Functional genomics can help deconvolute the link between genotype and phenotype in disease, revealing new drug targets and progressing understanding of existing drugs.

Successful test in breast cancer patients: the active agent digoxin, a cardiac medication, dissolves clusters of circulating breast cancer cells in the blood, thus reducing the risk of metastases formation.